KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation
Tai-Wei Li(The Ohio State University Wexner Medical Center), Jian Zhu(Nanjing Agricultural University)
Cited by 0
Related Papers
A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association
|Frontiers in Microbiology|2017|53
SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling
|Frontiers in Immunology|2022|26
SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation
|bioRxiv (Cold Spring Harbor Laboratory)|2021|21
Diversified Application of Barcoded PLATO (PLATO-BC) Platform for Identification of Protein Interactions
|Genomics Proteomics & Bioinformatics|2019|11
KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells
|Antiviral Research|2024|4